Table 4

Results of other studies investigating an escalation of the dose of WBI beyond 30 Gy in patients with brain metastases from a relatively radioresistant tumor.

Reference

Design

N patients

Tumor type

Median survival


Cannady et al. [8]

retrospective

46

renal cell carcinoma

30 Gy: 2.7 mos. >30 Gy: 8.5 mos.


Isokangas et al. [18]

retrospective

60

malignant melanoma

30 Gy: 4.1 mos. >30 Gy: 9.6 mos.


Present study

retrospective

164

various

30 Gy: 3.3 mos. >30 Gy: 9.5 mos


Meyners et al. BMC Cancer 2010 10:582   doi:10.1186/1471-2407-10-582

Open Data